Anti-UNC93B1 monoclonal antibody

Pre-made anti-UNC93B1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to UNC93B1/UNC93B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2246-Ab-1/ GM-Tg-hg-IP2246-Ab-2Anti-Human UNC93B1 monoclonal antibodyHuman
GM-Tg-rg-IP2246-Ab-1/ GM-Tg-rg-IP2246-Ab-2Anti-Rat UNC93B1 monoclonal antibodyRat
GM-Tg-mg-IP2246-Ab-1/ GM-Tg-mg-IP2246-Ab-2Anti-Mouse UNC93B1 monoclonal antibodyMouse
GM-Tg-cynog-IP2246-Ab-1/ GM-Tg-cynog-IP2246-Ab-2Anti-Cynomolgus/ Rhesus macaque UNC93B1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2246-Ab-1/ GM-Tg-felg-IP2246-Ab-2Anti-Feline UNC93B1 monoclonal antibodyFeline
GM-Tg-cang-IP2246-Ab-1/ GM-Tg-cang-IP2246-Ab-2Anti-Canine UNC93B1 monoclonal antibodyCanine
GM-Tg-bovg-IP2246-Ab-1/ GM-Tg-bovg-IP2246-Ab-2Anti-Bovine UNC93B1 monoclonal antibodyBovine
GM-Tg-equg-IP2246-Ab-1/ GM-Tg-equg-IP2246-Ab-2Anti-Equine UNC93B1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2246-Ab-1/ GM-Tg-hg-IP2246-Ab-2; GM-Tg-rg-IP2246-Ab-1/ GM-Tg-rg-IP2246-Ab-2;
GM-Tg-mg-IP2246-Ab-1/ GM-Tg-mg-IP2246-Ab-2; GM-Tg-cynog-IP2246-Ab-1/ GM-Tg-cynog-IP2246-Ab-2;
GM-Tg-felg-IP2246-Ab-1/ GM-Tg-felg-IP2246-Ab-2; GM-Tg-cang-IP2246-Ab-1/ GM-Tg-cang-IP2246-Ab-2;
GM-Tg-bovg-IP2246-Ab-1/ GM-Tg-bovg-IP2246-Ab-2; GM-Tg-equg-IP2246-Ab-1/ GM-Tg-equg-IP2246-Ab-2
Products NameAnti-UNC93B1 monoclonal antibody
Formatmab
Target NameUNC93B1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-UNC93B1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2246-Ag-1Recombinant multi-species UN93B/ UNC93B1/ IIAE1 protein
    ORF Viral VectorvGMLP002885human UNC93B1 Lentivirus particle
    ORF Viral VectorpGMLP002885human UNC93B1 Lentivirus plasmid


    Target information

    Target IDGM-IP2246
    Target NameUNC93B1
    Gene ID81622,54445,361689,710928,483692,101083453,508878,100059773
    Gene Symbol and SynonymsIIAE1,Unc-93B1,UNC93,UNC93B,UNC93B1
    Uniprot AccessionQ9H1C4
    Uniprot Entry NameUN93B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000110057
    Target ClassificationN/A

    The target: UNC93B1, gene name: UNC93B1, also named as IIAE1, UNC93, UNC93B, Unc-93B1. This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.